The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blood-based multiplex kinase activity profiling as a predictive marker for clinical response to checkpoint blockade in advanced melanoma.
 
Daan Hurkmans
No Relationships to Disclose
 
Els M.E. Verdegaal
Patents, Royalties, Other Intellectual Property - Pamgene
 
Sabrina A. Schindler
Travel, Accommodations, Expenses - Merck
 
Edwin A. Basak
No Relationships to Disclose
 
Dianne M.A. van den Heuvel
Employment - Pamgene
Patents, Royalties, Other Intellectual Property - Pamgene (Inst)
 
Rik de Wijn
Employment - Pamgene
Patents, Royalties, Other Intellectual Property - Pamgene
 
Rob Ruijtenbeek
Employment - Pamgene
Leadership - Pamgene
Patents, Royalties, Other Intellectual Property - Pamgene (Inst)
 
John P. Groten
Employment - Pamgene
Consulting or Advisory Role - Vitromics
Research Funding - Pamgene
 
Reinhard Dummer
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Stijn L.W. Koolen
Speakers' Bureau - Novartis
Research Funding - Cristal Therapeutics
Travel, Accommodations, Expenses - Boehringer Ingelheim; Ipsen
 
Marij J.P. Welters
No Relationships to Disclose
 
Ron H.J. Mathijssen
Research Funding - Astellas Pharma (Inst); Bayer Holding (Inst); Boehringer Ingelheim (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Ellen Kapiteijn
No Relationships to Disclose
 
Joachim G.J.V. Aerts
Stock and Other Ownership Interests - Amphera
Consulting or Advisory Role - Amphera; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Roche/Genentech
Speakers' Bureau - AstraZeneca
Patents, Royalties, Other Intellectual Property - an allogenic lysate for vaccination (Inst)
 
Mitchell P. Levesque
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Novartis; Roche
Patents, Royalties, Other Intellectual Property - EP 14 176 944.8 Levesque, MP, Widmer, D, Raaimakers, M, and Dummer, R. (2014). Means and methods for identifying a patient having a BRAF-positive cancer as a non-responder to a BRAF inhibitor and as a responder to an MAPK/ERK inhibitor. EP16203799.8 Eichh
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Sjoerd H. van der Burg
Consulting or Advisory Role - GlaxoSmithKline; iOMEDICO; ISA Pharmaceuticals
Research Funding - AIMM Therapeutics (Inst); CHDR (Inst); Innate Pharma (Inst); ISA Pharmaceuticals (Inst); Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - LUMC
Travel, Accommodations, Expenses - GlaxoSmithKline; iOMEDICO